NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

PRECIOUS-Gold jumps over 1% on U.S. stimulus bets

Published 12/07/2020, 11:37 PM
Updated 12/08/2020, 03:30 AM
© Reuters.
XAU/USD
-
XAG/USD
-
GC
-
SI
-

(Updates prices)
* Britain to begin Pfizer/BioNTech vaccine rollout this week
* Seasonally strong period for gold -analyst
* Interactive graphic tracking global spread of coronavirus:
open
* https://tmsnrt.rs/3aIRuz7 in an external browser

By Shreyansi Singh
Dec 7 (Reuters) - Gold gained more than 1% to a two-week
high on Monday, bolstered by expectations of fresh fiscal
stimulus in the United States.
Spot gold prices XAU= were 1.3% higher at $1,860.49 per
ounce by 2:04 p.m. EST (1904 GMT), after rising to their highest
level since Nov. 23 at $1,868.25 earlier. U.S. gold futures
GCv1 settled up 1.4% at $1,866.
"The stimulus plan has helped stabilize the gold market
because more money being pumped into the financial system is
inflationary," said Kitco Metals senior analyst Jim Wyckoff.
U.S. lawmakers sought to hammer out an agreement on infusing
long-awaited relief through a $908 billion bill.
Bullion is considered a hedge against inflation that could
result from the large stimulus measures unleashed in 2020,
gaining over 22% so far this year. Also on investors' radar, the United States imposed
sanctions and a travel ban on 14 Chinese officials over their
alleged role in Beijing's disqualification of elected opposition
legislators in Hong Kong. "This is a seasonally strong period for gold prices and we
just went through a capitalization event, in which a lot of the
weaker hands in gold have been shaken out of the market," said
Daniel Ghali, commodity strategist at TD Securities.
Gold has recovered more than 5% since slumping to a
five-month low on Nov. 30, with November also marking bullion's
worst month in four years, pressured by hopes of a
vaccine-fuelled economic recovery. Meanwhile, Britain was set to become the first country to
roll out the Pfizer/BioNTech COVID-19 vaccine this week.

On the technical front, the breach of the $1,850 resistance
level signals further gains for gold, analysts said.
Platinum XPT= was 2.1% lower at $1,031.92, having earlier
shed as much as 4.8%.
Silver XAG= gained 1.5% to $24.53 per ounce and palladium
XPD= fell 0.3% to $2,336.13.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.